Table 2 Descriptive changes over time in outcomes at visit 1, visit 2 and visit 3 in the MEDIM intervention study
Variables | Intervention | Control | ||||||
|---|---|---|---|---|---|---|---|---|
Visit 1 (n = 48) | Visit 2 (n = 33) | Visit 3 (n = 33) | Visit 1 (n = 44) | Visit 2 (n = 40) | Visit 3 (n = 31) | |||
Proneurotensin (pmol/L) (Median, IOR) | 119.3 (92.8–156.0) | 133.2 (109.6–167.0) | 147.5 (118.0–213.0) | 104.5 (90.4–156.6) | 115.5 (89.5–151.1) | 108.0 (88.1–143.2) | ||
Proneurotensin (natural logarithm) | 4.78 (0.40) | 4.89 (0.35) | 5.03 (0.41) | 4.75 (0.33) | 4.75 (0.35) | 4.72 (0.34) | ||
Body weight (kg) | 85.5 (15.2) | 85.2 (15.6) | 83.0 (15.0) | 80.0 (13.1) | 80.8 (12.8) | 80.8 (13.8) | ||
Body mass index (kg/m2) | 31.0 (4.4) | 30.8 (4.5) | 30.4 (4.3) | 29.6 (3.6) | 29.6 (3.6) | 29.6 (3.7) | ||
Physical activity (MET+-hours/week), median (IQR++) | 8.5 (0-47.6) | 65.8 (20.6-101.2) | 62.6 (23.1-151.1) | 12.4 (0-66.3) | 27.1 (1.9–126) | 24.0 (6.3–129) | ||
Total fat intake (g/d) | 86.1 (29.3) | 75.9 (28.3) | 75.2 (25.8) | 98.3 (34.6) | 96.2 (32.9) | 91.1 (30.0) | ||
Mean caloric intake (kcal) | 1886.3 (619) | 1740.4 (557.6) | 1692.6 (553.8) | 2052.3 (616) | 2055.9 (568) | 1941.3 (511.4) | ||